Cintia Piccina's most recent trade in Adaptimmune Therapeutics Plc - ADR was a trade of 1,612,032 Option to purchase Ordinary Shares done . Disclosure was reported to the exchange on Feb. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics P... | Cintia Piccina | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,612,032 | 1,612,032 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics P... | Cintia Piccina | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,074,696 | 1,074,696 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics P... | Cintia Piccina | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.57 per share. | 15 Jan 2025 | 12,991 | 18,421 (0%) | 0% | 0.6 | 7,467 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | Cintia Piccina | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.93 per share. | 18 Jun 2024 | 24,531 | 38,293 (0%) | 0% | 0.9 | 22,814 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | Cintia Piccina | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 5,088,864 | 5,088,864 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics P... | Cintia Piccina | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 1,130,832 | 1,130,832 | - | - | Option to purchase Ordinary Shares |